Literature DB >> 26989400

Risk Factors for New-Onset Cardiac Valve Calcification in Patients on Maintenance Peritoneal Dialysis.

Yunhuan Tian1, Sheng Feng1, Zhoubing Zhan1, Ying Lu1, Yancai Wang1, Shan Jiang1, Kai Song1, Huaying Shen1.   

Abstract

OBJECTIVE: Patients with end-stage renal disease are susceptible to cardiac valve calcification (CVC) due to mineral metabolism disorders and other factors. The purpose of this study was to investigate the risk factors for new-onset CVC in patients on maintenance peritoneal dialysis (PD).
METHODS: This study included patients who underwent PD catheter insertion from January 2006 to June 2013 in our Peritoneal Dialysis Center. Clinical data were collected on CVC status during echocardiography evaluations (twice) at an interval of >6 months. The data collected included intact parathyroid hormone, C-reactive protein (CRP), serum phosphorus (P), serum calcium (Ca), albumin (Alb), prealbumin and the use of five types of antihypertensive drugs, statins, active vitamin D3 and Ca tablets.
RESULTS: In total, 194 patients - 105 (54.1%) men, average age 60.5 ± 13.0 years - were included. CVC was present in 50 (25.8%) patients during PD catheter placement. After an average PD duration of 20.9 ± 10.4 months, CVC was detected in 97 patients (50.0%). New-onset CVC was found in 62 patients (32.0%). Multivariate logistic regression analysis revealed that only serum P levels (p = 0.01, OR = 2.569), Alb levels (p = 0.04, OR = 0.935), dialysis duration (p = 0.03, OR = 1.039) and CRP levels (p = 0.02, OR = 1.031) were associated with CVC.
CONCLUSION: Serum P, Alb and CRP levels as well as dialysis duration are independent risk factors for CVC.

Entities:  

Keywords:  Cardiac valve calcification; Peritoneal dialysis; Risk factor

Year:  2016        PMID: 26989400      PMCID: PMC4789884          DOI: 10.1159/000443620

Source DB:  PubMed          Journal:  Cardiorenal Med        ISSN: 1664-5502            Impact factor:   2.041


  24 in total

1.  Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?

Authors:  Karen Ann Herzig; David Michael Purdie; Wendy Chang; Allison Margaret Brown; Carmel Mary Hawley; Scott Bryan Campbell; Joanna Mary Sturtevant; Nicole Maree Isbel; David Lawrence Nicol; David Wayne Johnson
Journal:  J Am Soc Nephrol       Date:  2001-04       Impact factor: 10.121

2.  Active serum vitamin D levels are inversely correlated with coronary calcification.

Authors:  K E Watson; M L Abrolat; L L Malone; J M Hoeg; T Doherty; R Detrano; L L Demer
Journal:  Circulation       Date:  1997-09-16       Impact factor: 29.690

Review 3.  Arterial calcification in chronic kidney disease: key roles for calcium and phosphate.

Authors:  Catherine M Shanahan; Matthew H Crouthamel; Alexander Kapustin; Cecilia M Giachelli
Journal:  Circ Res       Date:  2011-09-02       Impact factor: 17.367

4.  Mitral annular calcification predicts mortality and coronary artery disease in end stage renal disease.

Authors:  Rajan Sharma; Denis Pellerin; David C Gaze; Rajnikant L Mehta; Helen Gregson; Christopher P Streather; Paul O Collinson; Stephen J D Brecker
Journal:  Atherosclerosis       Date:  2006-05-02       Impact factor: 5.162

5.  Comparison of serum albumin, serum C-reactive protein, and pulse wave velocity as predictors of the 4-year mortality of chronic hemodialysis patients.

Authors:  Nobuyuki Amemiya; Tetsuya Ogawa; Kuniaki Otsuka; Yoshitaka Ando; Kosaku Nitta
Journal:  J Atheroscler Thromb       Date:  2011-09-15       Impact factor: 4.928

6.  Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells.

Authors:  Neal X Chen; Kalisha D O'Neill; Danxia Duan; Sharon M Moe
Journal:  Kidney Int       Date:  2002-11       Impact factor: 10.612

7.  Phosphate regulation of vascular smooth muscle cell calcification.

Authors:  S Jono; M D McKee; C E Murry; A Shioi; Y Nishizawa; K Mori; H Morii; C M Giachelli
Journal:  Circ Res       Date:  2000-09-29       Impact factor: 17.367

8.  Prevalence and risk factors of valvular calcification in hemodialysis patients.

Authors:  Hayriye Sayarlioglu; Gurkan Acar; Murat Sahin; Orcun Altunoren; Yasemin Coskun Yavuz; Alper Bugra Nacar; Ekrem Dogan
Journal:  Iran J Kidney Dis       Date:  2013-03       Impact factor: 0.892

9.  Triad of malnutrition, inflammation, and atherosclerosis in hemodialysis patients.

Authors:  Siren Sezer; F Nurhan Ozdemir; Zübeyde Arat; Münire Turan; Mehmet Haberal
Journal:  Nephron       Date:  2002-07       Impact factor: 2.847

10.  Risk factor analysis of calcification in aortic and mitral valves in maintenance peritoneal dialysis patients.

Authors:  Chunyuan Wang; Linsen Jiang; Sheng Feng; Yongbing Shi; Huaying Shen; Xiaosong Shi; Zhi Wang; Yin Zeng
Journal:  Kidney Blood Press Res       Date:  2013-11-10       Impact factor: 2.687

View more
  2 in total

Review 1.  The Peritoneal Macrophages in Inflammatory Diseases and Abdominal Cancers.

Authors:  Ting Liu; Fang Liu; Lei-Wen Peng; Li Chang; Yong-Mei Jiang
Journal:  Oncol Res       Date:  2017-12-13       Impact factor: 5.574

2.  Differences between diabetic and non-diabetic nephropathy patients in cardiac structure and function at the beginning of hemodialysis and their impact on the prediction of mortality.

Authors:  Chao Tang; Han Ouyang; Jian Huang; Jing Zhu; Xiaosong Gu
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.